Cann American Corp. acquired Prodigy Stem Cell, LLC.
Cann American Corp. (OTCPK:CNNA) completed the acquisition of Prodigy Stem Cell, LLC on March 1, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0029 USD | -12.12% | -12.12% | -27.50% |
2023 | Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023 | CI |
2023 | Cann American Corp. Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-27.50% | 2.14M | |
+40.73% | 739B | |
+31.18% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.21% | 240B | |
+9.53% | 210B | |
-5.11% | 206B | |
+6.17% | 164B |